GL1X · GenesisL1 explorer

MolNFT v1 · #145552 · protein

Crystal structure of SHP2 E76K gof mutant in complex with SHP099

6CRG · Tyrosine-protein phosphatase non-receptor type 11: “Crystal structure of SHP2 E76K gof mutant in complex with SHP099”. X-ray diffraction, 2 ligands (5OD, SO4), 11 pockets (best druggability 0.67). MolNFT v1 #145552 on GenesisL1: 3D…

PDB
6CRG
Type
protein
Length
939 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein phosphatase non-receptor type 11
EC
3.1.3.48
UniProt
Q06124
Ligands
5OD, SO4
Pockets
11 · best druggability 0.67

Structure

x-ray diffraction · 2 distinct chains · 31% helix, 26% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48)protein47730% helix, 25% strandQ06124
BTyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48)protein46231% helix, 28% strandQ06124

Ligands and binding sites

  • 5OD · 6-(4-azanyl-4-methyl-piperidin-1-yl)-3-[2,3-bis(chloranyl)phenyl]pyrazin-2-amine · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 8 copies · chains A, B
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17370.670.7563empty
24030.660.80385OD
33940.650.79355OD, SO4
41260.480.7921SO4
5770.350.7616SO4

Interfaces

1 interface between chains.

  • A–B · 188 Ų buried · 3 hydrogen bonds · protein-protein

Compared structures

  • 6CRG · Crystal Structure of Shp2 E76K GOF Mutant in complex with SHP099 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.